Please use this identifier to cite or link to this item:
Title: Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension.
Austin Authors: Bonnet, Fabrice;Cooper, Mark E;Kawachi, H;Allen, Terri J;Boner, G;Cao, Zemin
Affiliation: Department of Medicine, University of Melbourne, Austin and Repatriation Medical Centre, Heidelberg West, Victoria, Australia
Issue Date: 1-Jul-2001
Publication information: Diabetologia; 44(7): 874-7
Abstract: The location of nephrin has been identified as the slit-diaphragm of the glomerular podocyte. Recent evidence suggests that nephrin could play a key role in the function of the glomerular filtration barrier and the development of proteinuria but its status in long-term diabetes is still not understood. We studied the expression of nephrin in a hypertensive model of diabetic nephropathy and investigated the potential influence of angiotensin II blockade on nephrin gene and protein expression.Streptozotocin-diabetic spontaneously hypertensive rats were given either no treatment or the angiotensin II antagonist, irbesartan, at a dose of 15 mg/kg per day by gavage for 32 weeks. Non-diabetic spontaneously hypertensive rats were used as a control group. Real time RT-PCR and immunohistochemistry were used to assess and quantify gene and protein expression of nephrin.Diabetic spontaneously hypertensive rats developed albuminuria and had a reduction in both gene and protein expression of nephrin when compared with control rats. Irbesartan treatment prevented the development of albuminuria and completely abrogated the down regulation of nephrin in diabetic rats.Long-term diabetes in spontaneously hypertensive rats is associated with a reduction in both gene and protein expression of nephrin within the kidney. These changes in nephrin levels were completely prevented by angiotensin II antagonist treatment, suggesting a potential novel mechanism to explain the antiproteinuric effect of agents which interrupt the renin-angiotensin system.
Gov't Doc #: 11508272
DOI: 10.1007/s001250100546
Journal: Diabetologia
Type: Journal Article
Subjects: Albuminuria.prevention & control
Analysis of Variance
Angiotensin Receptor Antagonists
Biphenyl Compounds.pharmacology
Diabetes Mellitus, Experimental.drug therapy.physiopathology
Disease Models, Animal
Gene Expression Regulation.drug effects
Hypertension.drug therapy
Membrane Proteins
Oligonucleotide Probes
Rats, Inbred SHR
Reverse Transcriptase Polymerase Chain Reaction
Appears in Collections:Journal articles

Files in This Item:
File Description SizeFormat 
11508272.pdf155.36 kBAdobe PDFThumbnail
Show full item record


checked on Jan 26, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.